| Identification of a Universal Group B Streptococcus Vaccine by Multiple Genome Screen D Maione, I Margarit, CD Rinaudo, V Masignani, M Mora, M Scarselli, ... Science 309 (5731), 148-150, 2005 | 667 | 2005 |
| Group B Streptococcus: global incidence and vaccine development AK Johri, LC Paoletti, P Glaser, M Dua, PK Sharma, G Grandi, R Rappuoli Nature Reviews Microbiology 4 (12), 932-942, 2006 | 443 | 2006 |
| Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. DL Kasper, LC Paoletti, MR Wessels, HK Guttormsen, VJ Carey, ... The Journal of clinical investigation 98 (10), 2308-2314, 1996 | 337 | 1996 |
| Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women CS Lachenauer, DL Kasper, J Shimada, Y Ichiman, H Ohtsuka, M Kaku, ... The Journal of infectious diseases 179 (4), 1030-1033, 1999 | 277 | 1999 |
| Safety and immunogenicity of capsular polysaccharide—tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib CJ Baker, LC Paoletti, MR Wessels, HK Guttormsen, MA Rench, ... The Journal of infectious diseases 179 (1), 142-150, 1999 | 245 | 1999 |
| Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus. MR Wessels, LC Paoletti, DL Kasper, JL DiFabio, F Michon, K Holme, ... The Journal of clinical investigation 86 (5), 1428-1433, 1990 | 244 | 1990 |
| Use of Capsular Polysaccharide—Tetanus Toxoid Conjugate Vaccine for Type II Group B Streptococcus in Healthy Women CJ Baker, LC Paoletti, MA Rench, HK Guttormsen, VJ Carey, ME Hickman, ... The Journal of infectious diseases 182 (4), 1129-1138, 2000 | 158 | 2000 |
| Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid … LC Paoletti, MR Wessels, AK Rodewald, AA Shroff, HJ Jennings, ... Infection and immunity 62 (8), 3236-3243, 1994 | 136 | 1994 |
| Immune response of healthy women to 2 different group B streptococcal type V capsular polysaccharide-protein conjugate vaccines CJ Baker, LC Paoletti, MA Rench, HK Guttormsen, MS Edwards, ... The Journal of infectious diseases 189 (6), 1103-1112, 2004 | 128 | 2004 |
| Structural and Immunochemical Characterization of the Type VIII Group B Streptococcus Capsular Polysaccharide (∗) G Kogan, D Uhrin, JR Brisson, LC Paoletti, AE Blodgett, DL Kasper, ... Journal of Biological Chemistry 271 (15), 8786-8790, 1996 | 127 | 1996 |
| Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and III CJ Baker, MA Rench, M Fernandez, LC Paoletti, DL Kasper, MS Edwards The Journal of infectious diseases 188 (1), 66-73, 2003 | 125 | 2003 |
| Stimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccine MR Wessels, LC Paoletti, AK Rodewald, F Michon, J DiFabio, ... Infection and immunity 61 (11), 4760-4766, 1993 | 125 | 1993 |
| Effects of in vitro and in vivo growth conditions on expression of type 8 capsular polysaccharide by Staphylococcus aureus JC Lee, S Takeda, PJ Livolsi, LC Paoletti Infection and immunity 61 (5), 1853-1858, 1993 | 125 | 1993 |
| Effects of chain length on the immunogenicity in rabbits of group B Streptococcus type III oligosaccharide-tetanus toxoid conjugates. LC Paoletti, DL Kasper, F Michon, J DiFabio, HJ Jennings, TD Tosteson, ... The Journal of clinical investigation 89 (1), 203-209, 1992 | 121 | 1992 |
| NMR and Molecular Dynamics Studies of the Conformational Epitope of the Type III Group B Streptococcus Capsular Polysaccharide and Derivatives JR Brisson, S Uhrinova, RJ Woods, M van der Zwan, HC Jarrell, ... Biochemistry 36 (11), 3278-3292, 1997 | 118 | 1997 |
| Role of glycan synthesis in colonization of the mammalian gut by the bacterial symbiont Bacteroides fragilis MJ Coyne, M Chatzidaki-Livanis, LC Paoletti, LE Comstock Proceedings of the National Academy of Sciences 105 (35), 13099-13104, 2008 | 117 | 2008 |
| Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes. LC Madoff, LC Paoletti, JY Tai, DL Kasper The Journal of clinical investigation 94 (1), 286-292, 1994 | 111 | 1994 |
| Hydroxamate production by Aquaspirillum magnetotacticum LC Paoletti, RP Blakemore Journal of bacteriology 167 (1), 73-76, 1986 | 106 | 1986 |
| Structural properties of group B streptococcal type III polysaccharide conjugate vaccines that influence immunogenicity and efficacy MR Wessels, LC Paoletti, HK Guttormsen, F Michon, AJ D’Ambra, ... Infection and immunity 66 (5), 2186-2192, 1998 | 103 | 1998 |
| Group B Streptococcus type II polysaccharide-tetanus toxoid conjugate vaccine LC Paoletti, MR Wessels, F Michon, J DiFabio, HJ Jennings, DL Kasper Infection and immunity 60 (10), 4009-4014, 1992 | 101 | 1992 |
Dennis KasperHarvard Medical SchoolVerified email at hms.harvard.edu
